{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T22:30:33Z","timestamp":1764714633641,"version":"3.40.4"},"reference-count":58,"publisher":"The Endocrine Society","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1998,11,1]]},"DOI":"10.1210\/endo.139.11.6307","type":"journal-article","created":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T16:08:52Z","timestamp":1389197332000},"page":"4642-4651","source":"Crossref","is-referenced-by-count":30,"title":["LY353381\u00b7HCl: An Improved Benzothiophene Analog with Bone Efficacy Complementary to Parathyroid Hormone-(1\u201334)"],"prefix":"10.1210","volume":"139","author":[{"given":"Masahiko","family":"Sato","sequence":"first","affiliation":[{"name":"Lilly Research Laboratories, Eli Lilly & Co., Lilly Corporate Center, Indianapolis, Indiana 46285;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George Q.","family":"Zeng","sequence":"additional","affiliation":[{"name":"Lilly Research Laboratories, Eli Lilly & Co., Lilly Corporate Center, Indianapolis, Indiana 46285;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellen","family":"Rowley","sequence":"additional","affiliation":[{"name":"Lilly Research Laboratories, Eli Lilly & Co., Lilly Corporate Center, Indianapolis, Indiana 46285;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles H.","family":"Turner","sequence":"additional","affiliation":[{"name":"Biomechanics and Biomaterials Research Center and Department of Orthopedic Surgery, Indiana University Medical Center (C.H.T.), Indianapolis, Indiana 46202"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","reference":[{"key":"2019041122022791600_R1","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1056\/NEJM198011203032102","article-title":"Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen.","volume":"303","author":"Weiss","year":"1980","journal-title":"N Engl J Med"},{"key":"2019041122022791600_R2","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S0140-6736(80)92592-1","article-title":"Prevention of spinal osteoporosis in oopherectomized women.","volume":"2","author":"Lindsay","year":"1980","journal-title":"Lancet"},{"key":"2019041122022791600_R3","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1016\/0002-9378(87)90025-1","article-title":"Estrogen therapy arrests bone loss in elderly women.","volume":"156","author":"Quigley","year":"1987","journal-title":"Am J Obstet Gynecol"},{"key":"2019041122022791600_R4","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/jbmr.5650050616","article-title":"Long-term estrogen replacement therapy in postmenopausal women sustains vertebral bone mineral density.","volume":"5","author":"Moore","year":"1990","journal-title":"J Bone Miner Res"},{"key":"2019041122022791600_R5","first-page":"161","article-title":"The effect of estrogens in prevention and treatment of osteoporosis. In: Munro H, Schlierf H (eds) Nutrition in the Elderly, Nestle Nutrition Workshop Series.","volume":"29","author":"Lindsay","year":"1992","journal-title":"Raven Press, New York, vol"},{"key":"2019041122022791600_R6","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1056\/NEJM197512042932303","article-title":"Increased risk of endometrial carcinoma among users of conjugated estrogens.","volume":"293","author":"Ziel","year":"1975","journal-title":"N Engl J Med"},{"key":"2019041122022791600_R7","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1056\/NEJM197512042932302","article-title":"Association of exogenous estrogen and endometrial carcinoma.","volume":"293","author":"Smith","year":"1975","journal-title":"N Engl J Med"},{"key":"2019041122022791600_R8","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1177\/014107688407700704","article-title":"Exogenous hormones in the aetiology of cancer in women.","volume":"77","author":"Vesey","year":"1984","journal-title":"J R Soc Med"},{"key":"2019041122022791600_R9","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1001\/jama.1991.03460150089030","article-title":"A meta-analysis of the effect of estrogen replacement therapy on the risk of breast cancer.","volume":"265","author":"Steinberg","year":"1991","journal-title":"JAMA"},{"key":"2019041122022791600_R10","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1001\/archinte.1991.00400010089011","article-title":"Menopausal estrogen replacement therapy and breast cancer.","volume":"151","author":"Dupont","year":"1991","journal-title":"Arch Intern Med"},{"key":"2019041122022791600_R11","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1056\/NEJM199706193362501","article-title":"Postmenopausal hormone therapy and mortality.","volume":"336","author":"Grodstein","year":"1997","journal-title":"N Engl J Med"},{"key":"2019041122022791600_R12","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1001\/jama.1997.03540380054031","article-title":"Patient-specific decisions about hormone replacement therapy in postmenopausal women.","volume":"277","author":"Col","year":"1997","journal-title":"JAMA"},{"key":"2019041122022791600_R13","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1056\/NEJM199712043372301","article-title":"Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women.","volume":"337","author":"Delmas","year":"1997","journal-title":"N Engl J Med"},{"key":"2019041122022791600_R14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01771666","article-title":"A pharmacological review of raloxifene.","volume":"14","author":"Bryant","year":"1996","journal-title":"J Bone Miner Metab"},{"key":"2019041122022791600_R15","first-page":"531","article-title":"Selective estrogen receptor modulators.","volume":"8","author":"Kaufman","year":"1996","journal-title":"DN&P"},{"key":"2019041122022791600_R16","first-page":"406","article-title":"Raloxifene efficacy in nonreproductive and reproductive tissues in rat models in vivo and in vitro","volume-title":"In Vitro Biology of Sex Steroid Hormone Action","author":"Sato","year":"1996"},{"key":"2019041122022791600_R17","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1172\/JCI116985","article-title":"Raloxifene (LY139481 HCl) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats.","volume":"93","author":"Black","year":"1994","journal-title":"J Clin Invest"},{"key":"2019041122022791600_R18","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1096\/fasebj.10.8.8666168","article-title":"Raloxifene, tamoxifen, nafoxidine, or estrogen effects on reproductive and non-reproductive tissues in ovariectomized rats.","volume":"10","author":"Sato","year":"1996","journal-title":"FASEB J"},{"key":"2019041122022791600_R19","doi-asserted-by":"crossref","DOI":"10.1016\/S0022-3565(24)37755-9","article-title":"LY353381\u00b7HCl: a novel raloxifene analog with improved SERM potency and efficacy in vivo","volume-title":"JPET","author":"Sato"},{"key":"2019041122022791600_R20","first-page":"690","article-title":"Anabolic actions of parathyroid hormone on bone.","volume":"14","author":"Dempster","year":"1993","journal-title":"Endocr Rev"},{"key":"2019041122022791600_R21","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/8756-3282(90)90210-P","article-title":"Restoration of axial and appendicular bone volumes by hPTH-(1\u201334) in parathyroidectomized and osteopenic rats.","volume":"11","author":"Tada","year":"1990","journal-title":"Bone"},{"key":"2019041122022791600_R22","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/jbmr.5650070503","article-title":"Intermittent administration of PTH-(1\u201334) increases serum 1,25 dihydroxyvitamin D concentrations and spinal bone density in senile (23 month) rats.","volume":"7","author":"Mitlak","year":"1992","journal-title":"J Bone Miner Res"},{"key":"2019041122022791600_R23","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1210\/endo.132.4.8462456","article-title":"The effect of recombinanat human (1\u201384) or synthetic human (1\u201334) parathyroid hormone on the skeleton of adult osteopenic ovariectomized rats.","volume":"132","author":"Kimmel","year":"1993","journal-title":"Endocrinology"},{"key":"2019041122022791600_R24","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/8756-3282(95)00077-Q","article-title":"Response of femoral neck to estrogen depletion and parathyroid hormone in aged rats.","volume":"16","author":"Li","year":"1995","journal-title":"Bone"},{"key":"2019041122022791600_R25","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/8756-3282(95)00115-T","article-title":"Parathyroid hormone monotherapy and cotherapy with antiresorptive agents restore vertebral bone mass and strength in aged ovariectomized rats.","volume":"16","author":"Li","year":"1995","journal-title":"Bone"},{"key":"2019041122022791600_R26","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1002\/jbmr.5650100616","article-title":"A comparison of the anabolic effects of parathyroid hormone at skeletal sites with moderate and severe osteopenia in aged ovariectomized rats.","volume":"10","author":"Qi","year":"1995","journal-title":"J Bone Miner Res"},{"key":"2019041122022791600_R27","doi-asserted-by":"crossref","first-page":"4330","DOI":"10.1210\/endo.138.10.5440","article-title":"Biosynthetic human PTH-(1\u201334) effects on bone quality in aged ovariectomized rats.","volume":"10","author":"Sato","year":"1997","journal-title":"Endocrinology"},{"key":"2019041122022791600_R28","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S8756-3282(97)00020-3","article-title":"A comparison of the effects of two anabolic agents (fluoride and PTH) on ash density and bone strength assessed in an osteopenic rat model.","volume":"20","author":"Sogaard","year":"1997","journal-title":"Bone"},{"key":"2019041122022791600_R29","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/S0140-6736(76)92216-9","article-title":"The anabolic effect of low doses of human parathyroid hormone fragment on the skeleton in postmenopausal osteoporosis.","volume":"1","author":"Reeve","year":"1976","journal-title":"Lancet"},{"key":"2019041122022791600_R30","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1136\/bmj.280.6228.1340","article-title":"Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutional osteoporosis: a multicenre trial.","volume":"280","author":"Reeve","year":"1980","journal-title":"Br Med J"},{"key":"2019041122022791600_R31","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1172\/JCI116273","article-title":"An evaluation of several biochemical markers for bone formation and resorption in a protocol utilizing cyclical parathyroid hormone and calcitonin therapy for osteoporosis.","volume":"91","author":"Hodsman","year":"1993","journal-title":"J Clin Invest"},{"key":"2019041122022791600_R32","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1056\/NEJM199412153312404","article-title":"Parathyroid hormone for the prevention of bone loss induced by estrogen deficiency.","volume":"331","author":"Finkelstein","year":"1994","journal-title":"N Engl J Med"},{"key":"2019041122022791600_R33","first-page":"232","article-title":"A small dose of human parathyroid hormone (1\u201334) increased bone mass in the lumbar vertebrae in patients with senile osteoporosis.","volume":"21","author":"Sone","year":"1995","journal-title":"Miner Electrolyte Metab"},{"key":"2019041122022791600_R34","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S0140-6736(97)02342-8","article-title":"Randomized controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis.","volume":"350","author":"Lindsay","year":"1997","journal-title":"Lancet"},{"key":"2019041122022791600_R35","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0169-6009(91)90124-I","article-title":"The ovariectomized rat model of postmenopausal bone loss.","volume":"15","author":"Kalu","year":"1991","journal-title":"Bone Miner"},{"key":"2019041122022791600_R36","first-page":"69","article-title":"The ovariectomized rat as an animal model for postmenopausal bone loss","volume":"S1","author":"Wronski","year":"1991","journal-title":"Cell Mater"},{"key":"2019041122022791600_R37","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0169-6009(92)90809-R","article-title":"On the rat model of human osteopenias and osteoporoses.","volume":"18","author":"Frost","year":"1992","journal-title":"Bone Miner"},{"key":"2019041122022791600_R38","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/jbmr.5650020206","article-title":"The effects of ovariectomy and 17\u03b2 estradiol on cortical bone histomorphometry in growing rats.","volume":"2","author":"Turner","year":"1987","journal-title":"J Bone Miner Res"},{"key":"2019041122022791600_R39","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1210\/endo-123-2-681","article-title":"Estrogen treatment prevents osteopenia and depresses bone turnover in ovariectomized rats.","volume":"123","author":"Wronski","year":"1988","journal-title":"Endocrinology"},{"key":"2019041122022791600_R40","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/BF02555891","article-title":"Progressive cancellous bone loss in rats after adrenalectomy and oophorectomy.","volume":"47","author":"Durbridge","year":"1990","journal-title":"Calcif Tiss Int"},{"key":"2019041122022791600_R41","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1210\/endo-122-3-1146","article-title":"Tamoxifen inhibits osteoclast mediated resorption of trabecular bone in ovarian hormone deficient rats.","volume":"122","author":"Turner","year":"1988","journal-title":"Endocrinology"},{"key":"2019041122022791600_R42","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0169-6009(91)90002-H","article-title":"A comparative study of the actions of tamoxifen, estrogen and progesterone in the ovariectomized rat.","volume":"15","author":"Kalu","year":"1991","journal-title":"Bone Miner"},{"key":"2019041122022791600_R43","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1210\/endo-129-3-1568","article-title":"Dose-dependent effects of tamoxifen on long bones in growing rats: Influence of ovarian status.","volume":"129","author":"Moon","year":"1991","journal-title":"Endocrinology"},{"key":"2019041122022791600_R44","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/S0022-3565(25)24554-2","article-title":"Longitudinal and cross-sectional analysis of Raloxifene effects on tibiae from ovariectomized aged rats.","volume":"272","author":"Sato","year":"1995","journal-title":"JPET"},{"key":"2019041122022791600_R45","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0022-3565(25)20968-5","article-title":"Advantages of raloxifene over alendronate or estrogen on non-reproductive and reproductive tissues in the long-term dosing of ovariectomized rats.","volume":"279","author":"Sato","year":"1996","journal-title":"JPET"},{"key":"2019041122022791600_R46","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S8756-3282(96)00313-4","article-title":"Comparative effects of droloxifene, tamoxifen, and estrogen on bone, serum cholesterol, and uterine histology in the ovariectomized rat model.","volume":"20","author":"Ke","year":"1997","journal-title":"Bone"},{"key":"2019041122022791600_R47","doi-asserted-by":"crossref","first-page":"3901","DOI":"10.1210\/endo.138.9.5358","article-title":"Dissection of the molecular mechanism of action of GW5638, a novel estrogen receptor ligand, provides insights into the role of estrogen receptor in bone.","volume":"138","author":"Willson","year":"1997","journal-title":"Endocrinology"},{"key":"2019041122022791600_R48","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1056\/NEJM199203263261302","article-title":"Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer.","volume":"326","author":"Love","year":"1992","journal-title":"N Engl J Med"},{"key":"2019041122022791600_R49","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/8756-3282(94)90816-8","article-title":"PTH has a more pronounced effect on vertebral bone mass and biomechanical competence than antiresorptive agents (estrogen and bisphosphonate) assessed in sexually mature, ovariectomized rats.","volume":"15","author":"Mosekilde","year":"1994","journal-title":"Bone"},{"key":"2019041122022791600_R50","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1172\/JCI118289","article-title":"Effects of reciprocal treatment with estrogen and estrogen plus parathyroid hormone on bone structure and strength in ovariectomized rats.","volume":"96","author":"Shen","year":"1995","journal-title":"J Clin Invest"},{"key":"2019041122022791600_R51","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/jbmr.5650020617","article-title":"Bone histomorphometry: standardization of nomenclature, symbols, and units.","volume":"2","author":"Parfitt","year":"1987","journal-title":"J Bone Miner Res"},{"key":"2019041122022791600_R52","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/8756-3282(93)90081-K","article-title":"Basic biomechanical measurments of bone: a tutorial.","volume":"14","author":"Turner","year":"1993","journal-title":"Bone"},{"key":"2019041122022791600_R53","first-page":"671","article-title":"Animal models for in vivo experimentation in osteoporosis research.","volume-title":"Osteoporosis","author":"Kimmel","year":"1996"},{"key":"2019041122022791600_R54","first-page":"659","article-title":"Analysis of estrogen receptor function in vitro reveals three distinct classes of antiestrogens.","volume":"9","author":"McDonnell","year":"1995","journal-title":"Mol Endocrinol"},{"key":"2019041122022791600_R55","doi-asserted-by":"crossref","first-page":"14105","DOI":"10.1073\/pnas.94.25.14105","article-title":"Molecular determinants of tissue selectivity in estrogen receptor modulators.","volume":"94","author":"Grese","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041122022791600_R56","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1126\/science.273.5279.1222","article-title":"Identification of an estrogen response element activated by metabolites of 17B estradiol and raloxifene.","volume":"273","author":"Yang","year":"1996","journal-title":"Science"},{"key":"2019041122022791600_R57","doi-asserted-by":"crossref","first-page":"4139","DOI":"10.1210\/endo.137.10.8828469","article-title":"Raloxifene inhibits bone turnover and prevents further cancellous bone loss in adult ovariectomized rats with established osteopenia.","volume":"137","author":"Evans","year":"1996","journal-title":"Endocrinology"},{"key":"2019041122022791600_R58","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1210\/endo.134.5.8156931","article-title":"The effects of raloxifene on tibia histomorphometry in ovariectomized rats.","volume":"134","author":"Evans","year":"1994","journal-title":"Endocrinology"}],"container-title":["Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/139\/11\/4642\/10348425\/endo4642.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T11:53:29Z","timestamp":1746100409000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/endo\/article\/139\/11\/4642\/2986888"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,11,1]]},"references-count":58,"journal-issue":{"issue":"11","published-print":{"date-parts":[[1998,11,1]]}},"URL":"https:\/\/doi.org\/10.1210\/endo.139.11.6307","relation":{},"ISSN":["0013-7227","1945-7170"],"issn-type":[{"type":"print","value":"0013-7227"},{"type":"electronic","value":"1945-7170"}],"subject":[],"published":{"date-parts":[[1998,11,1]]}}}